| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |